Skip to main content
. 2012 May 5;17(3):134–140. doi: 10.1016/j.rpor.2012.03.003

Fig. 1.

Fig. 1

Coverage by 95% of the prescribed dose: the upper part of the figure concerning the prostate (CTV2) and the lower part concerning the seminal vesicles (CTV1–2). 10-mm margin left and alternative 7-mm margin right.